Answers are grounded in this paper and cite their sources.
Each pre-COVID diagnoses and medication were associated with quantifiable increase post-COVID, with higher risk with advanced age, Black race and female gender. Single health system data may inhibit generalizability of our findings. Clinicians should be vigilant and prepared to manage post-COVID-19 polypharmacy.
No takes yet. Share an insight, caveat, or question.
Shakib et al. (2025) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: